Understanding immune responses to SARS-CoV2 infection
North Carolina Seronet Center for Excellence
This study is looking at how our immune system reacts to COVID-19, and it's for anyone who wants to help us learn more about immunity so we can create better treatments and vaccines—by sharing a blood sample, you can play a key role in this important research!
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10688366 on NIH RePORTER |
What this research studies
The UNC Center for Excellence in SARS-CoV2 Serologic Research investigates how the immune system responds to SARS-CoV2 infection. This research aims to characterize the immune responses, understand the mechanisms behind these responses, and identify factors that influence immune memory. By analyzing blood samples and immune responses, the research seeks to uncover important information that could help in developing better treatments and vaccines against COVID-19. Participants may contribute to this vital research by providing samples and data that enhance our understanding of immunity.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals who have been infected with SARS-CoV2 or those who have received a COVID-19 vaccine.
Not a fit: Patients who have not been infected with SARS-CoV2 and have not received a COVID-19 vaccine may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccines and treatments for COVID-19, enhancing patient protection against future infections.
How similar studies have performed: Other research has shown success in understanding immune responses to viral infections, making this approach promising for advancing COVID-19 knowledge.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Baric, Ralph S — Univ of North Carolina Chapel Hill
- Study coordinator: Baric, Ralph S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.